Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Avatrombopag is a novel oral, nonpeptide thrombopoietin receptor agonist (TPO-RA). A few studies have shown that avatrombopag is effective against thrombocytopenia. However, no systematic review has been conducted on the efficacy and safety of avatrombopag. Therefore, the aim of this stu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Pharmacol
Hoofdauteurs: Li, Chunlu, Li, Xiaoxuan, Huang, Feihong, Yang, Jing, Wu, Anguo, Wang, Long, Qin, Dalian, Zou, Wenjun, Wu, Jianming
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2019
Onderwerpen:
Pharmacology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6677019/
https://ncbi.nlm.nih.gov/pubmed/31402863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00829
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items